6533b826fe1ef96bd1283ac1

RESEARCH PRODUCT

Olanzepine-induced tardive dyskinesia

Piccoli FV. L. Bella

subject

medicine.medical_specialtyNeuroleptic therapybusiness.industryTardive dyskinesiamedicine.diseasePirenzepine030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineInternal medicinemedicine030212 general & internal medicinebusinessmedicine.drug

description

Tardive dyskinesia is a serious and common motor side-effect of treatment with traditional neuroleptics, with an unknown pathophysiological basis. It affects 20-30% of patients on long-term neuroleptic therapy, with elderly patients being at higher risk ( [American Psychiatric Association, 1994][1

https://doi.org/10.1192/bjp.182.1.81-b